Biotech Aps Wg - Net Worth and Insider Trading

Biotech Aps Wg Net Worth

The estimated net worth of Biotech Aps Wg is at least $56 Million dollars as of 2024-05-25. Biotech Aps Wg is the Director of Y-mAbs Therapeutics Inc and owns about 4,552,778 shares of Y-mAbs Therapeutics Inc (YMAB) stock worth over $56 Million. Details can be seen in Biotech Aps Wg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Biotech Aps Wg has not made any transactions after 2023-12-11 and currently still holds the listed stock(s).

Transaction Summary of Biotech Aps Wg

To

Biotech Aps Wg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Biotech Aps Wg owns 1 companies in total, including Y-mAbs Therapeutics Inc (YMAB) .

Click here to see the complete history of Biotech Aps Wg’s form 4 insider trades.

Insider Ownership Summary of Biotech Aps Wg

Ticker Comapny Transaction Date Type of Owner
YMAB Y-mAbs Therapeutics Inc 2023-12-11 10 percent owner

Biotech Aps Wg Latest Holdings Summary

Biotech Aps Wg currently owns a total of 1 stock. Biotech Aps Wg owns 4,552,778 shares of Y-mAbs Therapeutics Inc (YMAB) as of December 11, 2023, with a value of $56 Million.

Latest Holdings of Biotech Aps Wg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
YMAB Y-mAbs Therapeutics Inc 2023-12-11 4,552,778 12.22 55,634,947

Holding Weightings of Biotech Aps Wg


Biotech Aps Wg Form 4 Trading Tracker

According to the SEC Form 4 filings, Biotech Aps Wg has made a total of 9 transactions in Y-mAbs Therapeutics Inc (YMAB) over the past 5 years, including 5 buys and 4 sells. The most-recent trade in Y-mAbs Therapeutics Inc is the acquisition of 127,549 shares on December 11, 2023, which cost Biotech Aps Wg around $890,292.

Insider Trading History of Biotech Aps Wg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Biotech Aps Wg Trading Performance

GuruFocus tracks the stock performance after each of Biotech Aps Wg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Biotech Aps Wg is 122.39%. GuruFocus also compares Biotech Aps Wg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Biotech Aps Wg within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Biotech Aps Wg's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Biotech Aps Wg

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.14
Relative Return to S&P 500(%) 4.41

Biotech Aps Wg Ownership Network

Ownership Network List of Biotech Aps Wg

No Data

Ownership Network Relation of Biotech Aps Wg


Biotech Aps Wg Owned Company Details

What does Y-mAbs Therapeutics Inc do?

Who are the key executives at Y-mAbs Therapeutics Inc?

Biotech Aps Wg is the 10 percent owner of Y-mAbs Therapeutics Inc. Other key executives at Y-mAbs Therapeutics Inc include director & President and Chairman Thomas Gad , SVP and CMO Vignesh Rajah , and Senior Vice President & CCO Susan Laura Smith .

Y-mAbs Therapeutics Inc (YMAB) Insider Trades Summary

Over the past 18 months, Biotech Aps Wg made 5 insider transaction in Y-mAbs Therapeutics Inc (YMAB) with a net purchase of 380,768. Other recent insider transactions involving Y-mAbs Therapeutics Inc (YMAB) include a net purchase of 380,768 shares made by Johan Wedell-wedellsborg , a net sale of 336,251 shares made by Thomas Gad , and a net sale of 1,711 shares made by Vignesh Rajah .

In summary, during the past 3 months, insiders sold 39,644 shares of Y-mAbs Therapeutics Inc (YMAB) in total and bought 0 shares, with a net sale of 39,644 shares. During the past 18 months, 339,644 shares of Y-mAbs Therapeutics Inc (YMAB) were sold and 761,536 shares were bought by its insiders, resulting in a net purchase of 421,892 shares.

Y-mAbs Therapeutics Inc (YMAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Y-mAbs Therapeutics Inc Insider Transactions

No Available Data

Biotech Aps Wg Mailing Address

Above is the net worth, insider trading, and ownership report for Biotech Aps Wg. You might contact Biotech Aps Wg via mailing address: Rungsted Strandvej 113, Rungsted Kyst G7 2960.

Discussions on Biotech Aps Wg

No discussions yet.